Suppr超能文献

中国一家综合医院中肿瘤学家与癌症患者对补充替代医学的不同看法。

Discrepant Views of Oncologists and Cancer Patients on Complementary and Alternative Medicine in a Chinese General Hospital.

作者信息

Yang Geliang, Zhang Huiqing, Gan Zheng, Fan Yifu, Gu Wei, Ling Changquan

机构信息

1 Changhai Hospital of Traditional Chinese Medicine, Second Military Medical University, Shanghai, China.

出版信息

Integr Cancer Ther. 2018 Jun;17(2):451-457. doi: 10.1177/1534735417725579. Epub 2017 Sep 4.

Abstract

PURPOSE

Complementary and alternative medicine (CAM) has been widely used by cancer patients but rarely discussed by oncologists. This study was designed to evaluate the communication gap between China's oncologists and cancer patients on CAM.

METHODS

Two parallel cross-sectional studies assessed 83 oncologists and 402 cancer patients on CAM communication between patients and oncologists, and attitudes toward CAM use and clinical decisions about CAM.

RESULTS

A majority (75.1%) of the cancer patients (302/402) were identified as CAM users within the most recent three months while 77.6% of the cancer patients (312/402) were identified as CAM users since diagnosis of cancer. Oncologists and patients responded differently ( P < .001) on CAM communications. Both oncologists and patients expected that CAM could improve the immune system. They both agreed that oncologists usually discouraged their patients from using CAM. Regarding the effectiveness of CAM, cancer patients were more likely to believe that CAM was effective while oncologists had more concerns about adverse effects of CAM use. CAM use by patients was predicted by disease duration (≥9 months) in the multivariable logistic regression model.

CONCLUSION

China's oncologists and cancer patients may hold discrepant views on CAM. China's oncologists are encouraged to improve their knowledge on CAM and to initiate more discussions with their patients regarding effective and the safe use of CAM.

摘要

目的

补充和替代医学(CAM)已被癌症患者广泛使用,但肿瘤学家很少讨论。本研究旨在评估中国肿瘤学家与癌症患者在补充和替代医学方面的沟通差距。

方法

两项平行的横断面研究评估了83名肿瘤学家和402名癌症患者在患者与肿瘤学家之间关于补充和替代医学的沟通情况,以及对补充和替代医学使用的态度和关于补充和替代医学的临床决策。

结果

在最近三个月内,大多数(75.1%)癌症患者(302/402)被确定为补充和替代医学使用者,而自癌症诊断以来,77.6%的癌症患者(312/402)被确定为补充和替代医学使用者。肿瘤学家和患者在补充和替代医学沟通方面的反应不同(P <.001)。肿瘤学家和患者都期望补充和替代医学能改善免疫系统。他们都认为肿瘤学家通常不鼓励患者使用补充和替代医学。关于补充和替代医学的有效性,癌症患者更可能相信补充和替代医学有效,而肿瘤学家更担心使用补充和替代医学的不良反应。在多变量逻辑回归模型中,疾病持续时间(≥9个月)可预测患者对补充和替代医学的使用。

结论

中国肿瘤学家和癌症患者在补充和替代医学方面可能持有不同观点。鼓励中国肿瘤学家提高他们在补充和替代医学方面的知识,并就补充和替代医学的有效和安全使用与患者展开更多讨论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c077/6041901/c2b01aa8b2c1/10.1177_1534735417725579-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验